Stephen Forman, MD, City of Hope
Stephen J. Forman, MD has been Chair, Division of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center and Program Director, Hematologic Neoplasia, City of Hope Comprehensive Cancer Center since 1987. He first joined City of Hope in 1979 after completing a fellowship there. He attended medical school at the University of Southern California In addition to serving on the Phase One Medical Advisory Board, he is a member of the Scientific Advisory Board for the Cure for Lymphoma Foundation, a member of the Scientific Subcommittee of Transplant Biology for The American Society of Hematology, Chairman of the Marrow and Stem Cell Committee for the Southwest Oncology Group, and a member of the Gene Therapy Advisory Council, City of Hope and Beckman Research Institute.
Michael Lill, MD, Cedars-Sinai
Dr. Lill was born in Adelaide, Australia and attended medical school at the University of Western Australia where he graduated in 1982. His postgraduate medical training was initially in Western Australia at Sir Charles Gairdner and Royal Perth Hospitals where he trained in internal medicine, hematology and hematopathology. In 1989 Dr. Lill joined the Hematology/Oncology Fellowship Program at UCLA and in 1991 he was invited to join the faculty in the bone marrow transplant area at UCLA. In 1997 he joined Cedars-Sinai Medical Center as the Director of the Stem Cell/Bone Marrow Transplant Program. Dr. Lill is currently Chairman of the Cancer Committee, Chairman of the Hematology/Radiation Oncology Performance Improvement Committee and is actively involved in teaching, research and clinical care at Cedars-Sinai.
Auayporn Nademanee, MD, City of Hope
A fixture at City of Hope for over three decades, “Dr. Nadee,” as she’s known, specializes in bone marrow and stem cell transplantation, and working with the most difficult cases: patients whose lives depend on transplants from complete strangers. For over 15 years, Dr. Nademanee has directed Matched Unrelated Donor program at City of Hope’s Hematologic Malignancies and Stem Cell Transplantation Institute, which includes the Toni Stephenson Lymphoma Center, Gehr Family Center for Leukemia Research and Judy and Bernard Briskin Center for Multiple Myeloma Research. Dr. Nademanee and her team place special emphasis on patient safety, constantly searching for new ways to combat graft-versus-host disease, a serious risk when patients receive stem cells from genetically matched unrelated donors.
Gary Schiller, MD, UCLA Health System
Dr. Schiller is a well-published clinical investigator in acute and chronic leukemias, multiple myeloma, and other hematologic malignancies, as well as in stem cell and bone marrow transplantation. He lectures extensively, and has also written for the popular press. His research projects include clinical studies of new drugs, therapies, and bone marrow/stem cell transplantation for patients with malignancies of the blood or bone marrow such as leukemia, multiple myeloma, and lymphoma. He has carried out studies of stem cell transplantation following high-dose chemotherapy and radiation for acute myelogenous leukemia, one of the most common types of leukemia in adults. He has also carried out work with purified stem cell transplantation for multiple myeloma.
David Snyder, MD, City of Hope
A fixture at City of Hope for more than 30 years, David S. Snyder, MD is a nationally-recognized expert in stem cell transplantation for treating leukemia and a variety of other blood disorders, notably myeloproliferative neoplasms. Low-key, self-effacing but possessing encyclopedic knowledge, Dr. Snyder passionately believes in educating patients as well as his fellow physicians. He is frequently sought out for seminars, community presentations, educational videos and many other opportunities for sharing his insights. Dr. Snyder trained at Harvard Medical School and did multiple fellowships at Harvard Medical School and Tufts-New England Medical Center before joining City of Hope in 1984.
